Physician profile
Jade Gittens
NPI 1578799888
$2,615.08
in general payments reported to CMS, 2019-2025
16 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $87.58 · 2021: $440 · 2022: $169 · 2023: $1,139 · 2024: $479 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $898 · Food and Beverage: $808 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $898.20 |
| Food and Beverage | $807.85 |
| Education | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,149.18 | 2022-2025 | |
| Stryker Corporation | $663.89 | 2019-2024 | Variax, Easyfuse, Prostep |
| Amgen INC. | $153.98 | 2024 | Krystexxa |
| Djo, LLC | $112.00 | 2025 | Dr Comfort |
| Sebela Pharmaceuticals INC. | $87.85 | 2022-2023 | Naftin |
| Paratek Pharmaceuticals, INC. | $56.89 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $55.56 | 2019 | |
| Nevro Corp. | $53.43 | 2022-2023 | Senza |
| Convatec INC. | $47.08 | 2024 | |
| Zimmer Biomet Holdings, INC. | $46.54 | 2020 | |
| Smith+Nephew, INC. | $46.38 | 2019-2023 | Regranex, Collagenase Santyl |
| Medtronic, INC. | $45.35 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Wright Medical Technology, INC. | $41.04 | 2020 | |
| Organogenesis INC. | $28.99 | 2022 | |
| Paragon 28, INC. | $15.47 | 2025 | Hammertube Sterile Implant Kits |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Gittens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.